Wise Mind Herbs

 Evidence-based Herbal Healing

The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.

Ginger - Zingiber officinale

Ginger (Zingiber officinale) is a flowering plant whose rhizome is widely used as a spice and traditional medicine. It belongs to the family Zingiberaceae and is native to Southeast Asia. This review examines the current scientific understanding of ginger's health benefits, clinical applications, dosing guidelines, and safety profile based on peer-reviewed literature.

A ginger plant

Botanical Information and Common Names

The primary medicinal species is Zingiber officinale Roscoe. Ginger is known by various common names across different cultures including ginger root, adrak (Hindi), zanjabil (Arabic), jiang (Chinese), and shoga (Japanese). It should not be confused with wild ginger (Asarum species), which belongs to a different plant family and has different chemical constituents and properties. Blue ginger (Dichorisandra thyrsiflora) and Galangal (Alpinia galanga), sometimes called Thai ginger, are also entirely different plants despite similar naming.

Active Constituents

The pharmacological effects of ginger are primarily attributed to its bioactive compounds, including gingerols, shogaols, paradols, and zingerone. 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol are considered the most potent bioactive components. The composition varies based on whether the ginger is fresh (higher in gingerols) or dried/processed (higher in shogaols, which are more potent).

Evidence-Based Health Benefits

Scientific research has demonstrated several therapeutic properties of ginger through in vitro, animal, and human clinical studies:

Specific Conditions with Supporting Evidence

Recommended Dosages

Dosage varies by form and indication. Current evidence supports the following ranges:

Most clinical trials showing efficacy have used standardized extracts containing 5-10% gingerols, particularly for anti-inflammatory and pain management applications. The ratio of gingerols to shogaols appears important for specific therapeutic effects.

High-Dose Studies and Efficacy Threshold

Studies have investigated doses up to 4g daily of dried ginger powder and 2g daily of standardized extract. Evidence suggests a plateau effect in therapeutic benefit beyond 2g daily for most conditions. Studies examining doses exceeding 5g daily are limited, though some safety assessments have evaluated short-term use of up to 10g without serious adverse effects in healthy individuals. A significant knowledge gap exists regarding long-term safety and efficacy of high-dose ginger supplementation beyond 3 months of continuous use. Research indicates potential for increased bleeding risk at doses exceeding 4g daily, particularly when combined with anticoagulant medications.

Side Effects and Safety Profile

Ginger is generally recognized as safe (GRAS) by the FDA when consumed in food amounts. Reported side effects from supplemental doses include:

Contraindications and Precautions

Limitations of Current Research

Despite promising results, ginger research faces several limitations: high heterogeneity in study design and quality, variable standardization of ginger preparations across studies, limited long-term safety data beyond 3 months, and insufficient dose-response studies for many conditions. Many potential therapeutic applications remain in preliminary research phases, requiring larger, well-designed trials to confirm efficacy.

Conclusion

Current scientific evidence strongly supports ginger's efficacy for nausea (various causes) and provides moderate support for its use in inflammatory conditions, especially osteoarthritis. Its favorable safety profile at recommended doses makes it a viable complementary approach for several conditions. However, ginger should not be considered curative for any medical condition, and its use should be discussed with healthcare providers, particularly for individuals on medication or with existing health conditions.

References

Anh, N. H., Kim, S. J., Long, N. P., Min, J. E., Yoon, Y. C., Lee, E. G., ... & Kwon, S. W. (2020). Ginger on human health: a comprehensive systematic review of 109 randomized controlled trials. Nutrients, 12(1), 157.

Bartels, E. M., Folmer, V. N., Bliddal, H., Altman, R. D., Juhl, C., Tarp, S., ... & Christensen, R. (2015). Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and cartilage, 23(1), 13-21.

El Gayar, M. H., Aboromia, M. M., Ibrahim, N. A., & Hafiz, M. H. A. (2019). Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus. Obesity Medicine, 14, 100094.

Harun, N. H., & Mohamad, M. F. (2022). The immunomodulatory effects of Zingiber officinale (ginger): A systematic review. Research Journal of Pharmacy and Technology, 15(8), 3776-3781.

Jalali, M., Mahmoodi, M., Moosavian, S. P., Jalali, R., Ferns, G., Mosallanezhad, A., ... & Mosallanezhad, Z. (2020). The effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 34(8), 1723-1733. Morvaridzadeh, M., Fazelian, S., Agah, S., Khazdouz, M., Rahimlou, M., Agh, F., ... & Heshmati, J. (2020). Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine, 135, 155224.

Panahi, Y., Saadat, A., Sahebkar, A., Hashemian, F., Taghikhani, M., & Abolhasani, E. (2012). Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integrative cancer therapies, 11(3), 204-211.

Tiani, K. A., Arenaz, C. M., Spill, M. K., Foster, M. J., Davis, J. S., Bailey, R. L., ... & MacFarlane, A. J. (2024). The use of ginger bioactive compounds in pregnancy: an evidence scan and umbrella review of existing meta-analyses. Advances in Nutrition, 15(11), 100308.

Wang, J., Ke, W., Bao, R., Hu, X., & Chen, F. (2017). Beneficial effects of ginger Zingiber officinale Roscoe on obesity and metabolic syndrome: a review. Annals of the New York academy of sciences, 1398(1), 83-98.